Ascend, Mayne settle with US states for $1m in generic-drug antitrust case
MLex Summary: Ascend Laboratories and Mayne Pharma agreed to pay $1 million to settle US antitrust claims filed by 48 state attorneys general over generic drug pricing, New York Attorney General...To view the full article, register now.
Already a subscriber? Click here to view full article